Yazan Madanat, Leukemia Director and Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, shared a post on X:
“Honored to present at the 4th Translational Summit on Heme Malignancies! Updates from the KOMET-007 Ziftomenib combo trial – grateful to be part of an incredible Menin inhibitor session with such a stellar lineup.”
More posts featuring Yazan Madanat on OncoDaily.
